Legal

Accessibility statement

Information on the digital accessibility of LIGHV / NOVVIA PHARM GmbH services.

Information pursuant to Annex 3 of the German Accessibility Strengthening Act (BFSG).

As of: 24 July 2026

1. Scope

This information applies to the publicly accessible digital services of the LIGHV brand of NOVVIA PHARM GmbH (including under www.lighv.com), covering the public website and the protected professional portal for pharmacies and physicians.

Where the German Accessibility Strengthening Act (BFSG) and its ordinance (BFSGV) apply to our digital services, we hereby provide the information required under Annex 3 BFSG.

2. General description of the service

LIGHV is the B2B brand of NOVVIA PHARM GmbH for wholesale medical cannabis to pharmacies. The website informs about the company, quality and partnership. In the professional portal, approved professionals can view the product range, access specialist information and prepare or place orders.

3. Notes on how the service is used

The website and portal are used via common desktop and mobile browsers. The professional portal requires registration or sign-in (including professional verification and approval). Public content is available without login. Forms (e.g. contact) and cookie settings are available via the respective page or the footer.

4. Meeting accessibility requirements

We are guided by the requirements of the BFSGV and the harmonised standard EN 301 549 (aligned with WCAG 2.2 Level AA) and implement them step by step. This includes in particular:

  • semantic HTML structure and a clear heading hierarchy,
  • keyboard operability of essential navigation and forms,
  • sufficient contrast in the core LIGHV brand layouts,
  • alternative text for content images where provided editorially,
  • visible focus and consistent controls,
  • avoiding colour alone as the only means of conveying information in central UI elements.

Third-party technical components (e.g. cookie banner, DocCheck login, embedded media or PDF downloads) may have limitations. We continuously work on improvements and prioritise feedback.

5. Feedback and contact

If you encounter barriers or need support using our services, please contact us. We aim to respond promptly.

NOVVIA PHARM GmbH
Am Lohmühlbach 13
85356 Freising
Germany

Phone: +49 (0) 8161 96 99 4-50
Email: info@novvia-pharm.de
Contact form: Contact page

6. Competent market surveillance authority

The authority responsible for market surveillance of the accessibility of products and services under the BFSG is:

Marktüberwachungsstelle der Länder für die Barrierefreiheit von Produkten und Dienstleistungen (MLBF)
c/o Ministry of Labour, Social Affairs, Health and Equality of the State of Saxony-Anhalt
Turmschanzenstraße 25
39114 Magdeburg
Germany

Phone: +49 (0) 391 567 4530
Email: MLBF@ms.sachsen-anhalt.de

7. Currency

This information was created or last updated on 24 July 2026. We revise it when our digital services change materially.

Cookies & privacy

We use technically necessary cookies so the website works. Optional cookies for statistics (e.g. Matomo) and marketing are set only with your consent (Art. 6(1)(a) GDPR, § 25(1) TDDDG). You can accept all, allow only necessary cookies, or customise your choice. Details in the privacy policy. You can change your decision anytime via “Cookie settings”.

Cookies & privacy

We use technically necessary cookies so the website works. Optional cookies for statistics (e.g. Matomo) and marketing are set only with your consent (Art. 6(1)(a) GDPR, § 25(1) TDDDG). You can accept all, allow only necessary cookies, or customise your choice. Details in the privacy policy. You can change your decision anytime via “Cookie settings”.
Your cookie settings have been saved.